Male sexual behavior and human papillomavirus DNA: Key risk factors for cervical cancer in Spain

Journal of the National Cancer Institute

Volumn 88, Issue 15, 1996, Pages 1060-1067

  Bosch, F Xavier ^a   Castellsagué, Xavier ^a   Muñoz, Nubia ^b   De Sanjosé, Silvia ^a   Ghaffari, Anthony M ^c   González, Luís C ^d   Gili, Miguel ^e   Izarzugaza, Isabel ^f   Viladiu, Pau ^g   Navarro, Carmen ^h   Vergara, Alberto ⁱ   Ascunce, Nieves ^j   Guerrero, Eloisa ^c   Shah, Keerti V ^c  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Serv Terr Sanid Bienestar Social   (Spain)

^e UNIVERSITY OF SEVILLE   (Spain)

^f Ayuntamiento de Vitoria Gasteiz   (Spain)

^g Dementia Unit   (Spain)

^h Instituto Murciano de Investigación Biosanitaria Arrixaca   (Spain)

ⁱ Servicio Provincial de Agricultura   (Spain)

^j Programa de Cáncer de Mama   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER RISK; CHLAMYDIA TRACHOMATIS; CONDYLOMA; CONTROLLED STUDY; EDUCATION; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; PENIS GLANS; POLYMERASE CHAIN REACTION; PROSTITUTION; SEXUAL BEHAVIOR; SMOKING; SPAIN; SPOUSE; TREPONEMA PALLIDUM; URETHRA; UTERINE CERVIX CANCER; WART VIRUS;

EID: 9344252797     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.15.1060     Document Type: Article

References (43)

1. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
2. Munoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992;52:743-9.
3. Bosch FX, Munoz N, de Sanjose S, Navarro C, Moreo P, Ascunce N, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:415-22.
4. Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994;69:114-9.
5. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group [see comment citation in Medline]. J Natl Cancer Inst 1995;87:796-802.
6. Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR, et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993;20:274-8.
7. Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex Transm Dis 1993;20:279-85.
8. Wheeler CM, Parmenter CA, Hunt WC, Becker TM, Greer CE, Hildesheim A, et al. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 1993; 20:286-9.
9. Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, et al. Determinants of genital human papillomavirus infection in young women [see comment citations in Medline]. J Natl Cancer Inst 1991; 83:997-1003.
10. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method [see comment citation in Medline]. JAMA 1991;265:472-7.
11. Bosch FX, Munoz N, de Sanjose S, Izarzugaza I, Gili M, Viladiu P, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992;52:750-8.
12. Munoz N, Bosch FX, de Sanjose S, Vergara A, del Moral A, Munoz MT, et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2: 423-31.
13. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia [see comment citations in Medline]. J Natl Cancer Inst 1993;85: 958-64.
14. Bosch FX, Cardis E. Cancer incidence correlations: genital, urinary and some tobacco-related cancers. Int J Cancer 1990;46:178-84.
15. Li JY, Li FP, Blot WJ, Miller RW, Fraumeni JF Jr. Correlation between cancers of the uterine cervix and penis in China. J Natl Cancer Inst 1982;69:1063-5.
16. Franco EL, Campos-Filho N, Villa LL, Torloni H. Correlation patterns of cancer relative frequencies with some socioeconomic and demographic indicators in Brazil: an ecologic study. Int J Cancer 1988;41:24-9.
17. Martinez I. Relationship of squamous cell carcinoma of the cervix uteri to squamous cell carcinoma of the penis among Puerto Rican women married to men with penile carcinoma. Cancer 1969;24:777-80.
18. Graham S, Priore R, Graham M, Browne R, Burnett W, West D. Genital cancer in wives of penile cancer patients. Cancer 1979;44:1870-4.
19. Smith PG, Kinlen LJ, White GC, Adelstein AM, Fox AJ. Mortality of wives of men dying with cancer of the penis. Br J Cancer 1980;41:422-8.
20. Kessler II. Venereal factors in human cervical cancer: evidence from marital clusters. Cancer 1977;39(4 Suppl):1912-9.
21. Beral V. Cancer of the cervix: a sexually transmitted infection? Lancet 1974;1:1037-40.
22. Pridan H, Lilienfeld AM. Carcinoma of the cervix in Jewish women in Israel, 1960-67: an epidemiological study. Isr J Med Sci 1971;7: 1465-70.
23. Buckley JD, Harris RW, Doll R, Vessey MP, Williams PT. Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet 1981;2:1010-5.
24. Slattery ML, Overall JC Jr, Abbott TM, French TK, Robison LM, Gardner J. Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis. Am J Epidemiol 1989;130:248-58.
25. Brinton LA, Reeves WC, Brenes MM, Herrero R, Gaitan E, Tenorio F, et al. The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer 1989;44:199-203.
26. Zunzunegui MV, King MC, Coria CF, Charlet J. Male influences on cervical cancer risk. Am J Epidemiol 1986;123:302-7.
27. Kjaer SK, de Villiers EM, Dahl C, Engholm G, Bock JE, Vestergaard BF, et al. Case-control study of risk factors for cervical neoplasia in Denmark. I: Role of the "male factor" in women with one lifetime sexual panner. Int J Cancer 1991;48:39-44.
28. Munoz N, Castellsague X, Bosch FX, Tafur L, de Sanjose S, Aristizabal N, et al. Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J Natl Cancer Inst 1996;88:1068-75.
29. de Sanjose S, Munoz N, Bosch FX, Reimann K, Pedersen NS, Orfila J, et al. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 1994;56:358-63.
30. Bosch FX, Munoz N, de Sanjose S, Guerrerro E, Gaffari AM, Kaldor J, et al. Importance of human papillomavirus endemicity in the incidence of cervical cancer: an extension of the hypothesis on sexual behavior [published erratum appears in Cancer Epidemiol Biomarkers Prev 1994;3:718]. Cancer Epidemiol Biomarkers Prev 1994;3:375-9.
31. Richart RM. Cervical intraepithelial neoplasia. In: Sommers BC, editor. Pathology annual. New York: Appleton-Century-Crofts, 1973:301-28.
32. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women [see comment citation in Medline]. J Infect Dis 1994;169:235-40.
33. Bauer H, Greer C, Manos M. Detection of genital human papillomavirus infection using PCR. In: Herrington CS, McGee JO, editors. Diagnostic molecular pathology: a practical approach. Oxford: Oxford Univ Press, 1992: 131-52.
34. Manos MM, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In: Furth M, Greaves M, editors. Molecular diagnostics of human cancer. Cold Spring Harbor (NY): Cold Spring Harbor Press, 1989:209-14.
35. Gravitt PE, Manos MM. Polymerase chain reaction-based methods for the detection of human papillomavirus DNA. IARC Sci Publ 1992;119:121-33.
36. Breslow NE, Day NE. Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ 1980;32: 5-338.
37. Skegg DC, Corwin PA, Paul C, Doll R. Importance of the male factor in cancer of the cervix. Lancet 1982;2:581-3.
38. Munoz N, Kato I, Bosch FX, de Sanjose S, Sundquist VA, Izarzugaza I, et al. Cervical cancer and herpes simplex virus type 2: case-control studies in Spain and Colombia, with special reference to immunoglobulin-G subclasses. Int J Cancer 1995;60:438-42.
39. Slattery ML, Robison LM, Schuman KL, French TK, Abbott RM, Overall JC Jr, et al. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer [see comment citation in Medline]. JAMA 1989; 261:1593-8.
40. Coker AL, Rosenberg AJ, McCann MF, Hulka BS. Active and passive cigarette smoke exposure and cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1992;1: 349-56.
41. Sasson IM, Haley NJ, Hoffmann D, Wynder EL, Hellberg D, Nilsson S. Cigarette smoking and neoplasia of the uterine cervix: smoke constituents in cervical mucus [letter]. N Engl J Med 1985;312:315-6.
42. Jones CJ, Schiffman MH, Kurman R, Jacob P 3d, Benowitz NL. Elevated nicotine levels in cervical lavages from passive smokers. Am J Public Health 1991;81:378-9.
43. Schiffman MH, Haley NJ, Felton JS, Andrews AW, Kaslow RA, Lancaster WD, et al. Biochemical epidemiology of cervical neoplasia: measuring cigarette smoke constituents in the cervix. Cancer Res 1987;47:3886-8.